Risk Factors for Neurodegeneration

Risk factors for neurodegeneration include trauma, lifestyle, and allelic variants of disease-associated genes with incomplete penetrance. Here is the latest research.

January 16, 2022
Preprint
Open Access

JOINT CONTRIBUTION OF MARKERS OF NEURODEGENERATION AND HYPERCHOLESTEROLEMIA TO DEMENTIA RISK

MedRxiv : the Preprint Server for Health Sciences
Laura PernaH. Brenner
January 15, 2022
Preprint
Open Access

Mitochondrial and redox modifications in early stages of Huntington disease

BioRxiv : the Preprint Server for Biology
C. LopesAna Cristina Rego
January 15, 2022
Open Access

Family history of FXTAS is associated with age-related cognitive-linguistic decline among mothers with the FMR1 premutation.

Journal of Neurodevelopmental Disorders
Jessica KlusekLeonard Abbeduto
January 15, 2022

Effect of FOXO3 and Air Pollution on Cognitive Function: A Longitudinal Cohort Study of Older Adults in China from 2000 to 2014.

The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
John S JiLijing L Yan
January 14, 2022

The Importance of Diagnostic and Prognostic Biomarker Identification and Classification Towards Understanding ALS Pathogenesis.

Advances in Experimental Medicine and Biology
Katerina Kadena, Panayiotis Vlamos
January 14, 2022

Biomarker-Driven Analysis Using High-Throughput Approaches in Neuroinflammation and Neurodegenerative Diseases.

Advances in Experimental Medicine and Biology
Marios G Krokidis
January 14, 2022
Review

Genetics and functional genomics of multiple sclerosis.

Seminars in Immunopathology
Woori Kim, Nikolaos A Patsopoulos
January 14, 2022
Open Access

Sublethal enteroviral infection exacerbates disease progression in an ALS mouse model.

Journal of Neuroinflammation
Yuan Chao XueHonglin Luo
January 13, 2022
Review

Phosphorylated tau as a toxic agent in synaptic mitochondria: implications in aging and Alzheimer's disease.

Neural Regeneration Research
Angie K TorresCheril Tapia-Rojas
January 13, 2022

High-Frequency Ultrasound Activation of Perfluorocarbon Nanodroplets for Treatment of Glaucoma.

IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
Ronald H SilvermanGulgun Tezel
January 13, 2022
Review

Impact of Testosterone on Alzheimer's Disease.

The World Journal of Men's Health
Vittorio Emanuele Bianchi
January 12, 2022
Preprint
Open Access

Single-nucleus RNA-seq of normal-appearing brain regions in relapsing-remitting vs. secondary progressive multiple sclerosis

BioRxiv : the Preprint Server for Biology
Yasuyuki KiharaJ. Chun
January 12, 2022
Review
Open Access

Pathomechanisms of Vascular Depression in Older Adults.

International Journal of Molecular Sciences
Kurt A Jellinger
January 12, 2022
Review
Open Access

LRRK2 at Striatal Synapses: Cell-Type Specificity and Mechanistic Insights.

Cells
Patrick D SkeltonLoukia Parisiadou
January 12, 2022
Review
Open Access

Effect of Physical Activity, Smoking, and Sleep on Telomere Length: A Systematic Review of Observational and Intervention Studies.

Journal of Clinical Medicine
Rocío BarragánDolores Corella
January 10, 2022
Open Access

The Alzheimer susceptibility gene BIN1 induces isoform-dependent neurotoxicity through early endosome defects.

Acta Neuropathologica Communications
Erwan LambertPierre Dourlen
January 10, 2022

NFE2L1-mediated proteasome function protects from ferroptosis.

Molecular Metabolism
Stefan KotschiAlexander Bartelt
January 10, 2022
Review

Current understandings and perspectives of petroleum hydrocarbons in Alzheimer's disease and Parkinson's disease: a global concern.

Environmental Science and Pollution Research International
Rajalakshmi RajendranBijo Mathew

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved
/feed-previews/risk-factors-for-neurodegeneration/fb426a8c-650c-432d-853f-563e3adde4c0